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ABSTRACTSObjective: To determine whether ethnic differences exist in circulating
markers of angiogenesis between South Asians, Blacks and Whites. To
determine associations between these markers, cardiovascular risk factors
and Peripheral arterial disease (PAD).
Patients and Methods: We recruited 255 subjects (86 South Asians, 81
Blacks and 79 Whites) between October 2008 and September 2009
attending Sandwell & West Birmingham Hospitals NHS Trust. Subjects
were separated into radiologically conﬁrmed symptomatic PAD, risk factor
controls (At least 1 cardiovascular risk factor& Ankle Brachial Pressure
Index (ABPI)>1) and healthy volunteers (No cardiovascular risk factors&
ABPI>1). All subjects completed a questionnaire, anthrompometric
measurements and phlebotomy was undertaken. Enzyme linked immu-
noassay (ELISA) was used to quantify angiogenic markers.
Results: Whites had lower angiogenin concentration than both South
Asians and Blacks (p¼0.0217 and p¼0.003 respectively). Angiogenin was
higher in diabetics than non-diabetics (p¼0.0338). Ang-1 and Ang-2 were
correlated with Age (p¼0.007 and p¼0.006 respectively). Ang-2 was
higher in coronary artery disease (p¼0.0176) and PAD (p¼0.0018). The
association between Ang-2 and PAD was apparent in both South Asians
(p¼0.0084) and Whites (p¼0.0484).
Conclusions: Ethnic differences in angiogenic markers are evident. This
may reﬂect susceptibility of particular groups to PAD. Of the angiogenic
markers, Ang-2 was higher in symptomatic PAD; its levels increasing with
advancing disease.SARS Academic and Research Prize 0275 CONTRAST ENHANCED AORTIC
DUPLEX ULTRASONOGRAPHY SCANNING (CEADUSS) – A LABORATORY
MODEL PHANTOM TO COMPARE AND DETERMINE THE LIMITATIONS
OF ENHANCED AND UNENHANCED ULTRASONOGRAPHY SCANNING
FOR POST-OPERATIVE SURVEILLANCE OF ENDOVASCULAR ABDOMINAL
AORTIC ANEURYSM REPAIR (EVAR)
S. Dindyal, A. Sud, M. Brewin, A. Thrush, M. Birch, C. Kyriakides. The Royal
London Hospital, Whitechapel, London, UK
Objectives: To detect the subgroup of patients whom may require post-
EVAR intervention, currently all patients undergoing endovascular treat-
ments enter a programme of surveillance, usually with regular CT scan
follow-up.
We propose ultrasound may be suitable non-invasive follow-up investi-
gation and we aimed to determine the absolute limitations of ultrasound
in detecting low ﬂow endoleaks and compare the effects of the addition of
microbubble contrast enhancement.
Methods: We constructed an EVAR-simulation-phantom with endoleak
represented by a smaller lumen with variable ﬂow alongside the ﬁxed
stent. Distances between the two vessels was varied by viewing from set
stent positions and ﬂows were viewed from anterior, posterior or lateral.
Subjects consisted of ultrasonographers, who examining the phantoms
geometric parameters with colour doppler then repeated using CEADUSS.
Results: Anterior endoleaks were detected more frequently than lateral
then posterior positioned leaks were the most difﬁcult to detect. The
addition of contrast improved anterior leak detection from 76.4% to 98.6%
(P<0.001) and also lateral endoleaks from 59.7% to 77.8% (P<0.05).
However, posterior endoleak detection was not signiﬁcantly improved
(62.5% to 61.1%).
Conclusion: We have demonstrated that endoleak certainity is improved
signiﬁcantly by using microbubble contrast enhancement and should be
considered a adjunct for routine EVAR surveillance.SARS Academic and Research Prize 0277 SMA – A NEW PROGNOSTIC
MARKER IN ORAL CANCERS
Dan Marsh 1, Kerry Chester 3, Gareth Thomas 2. 1 Lister Hospital, Stevenage,
UK; 1 Southampton Medical School, Southampton, UK; 1UCL Cancer Institute,
London, UK
Introduction: Worldwide, approximately 405 000 cases of oral cancer
(OSCC) are diagnosed each year, with a 5-year survival rate of around 50%.
Although patients with advanced disease show reduced survival, there is
no single pathological or molecular feature that identiﬁes aggressive,
early-stage tumours.Method: We retrospectively analysed 282 OSCC and found that the
strongest independent risk factor of early OSCC death was a feature of
stroma rather than tumour cells.
Results: After adjusting for all factors, high stromal SMA expression,
indicating myoﬁbroblast transdifferentiation, produced the highest hazard
ratio (3.06, 95% CI 1.65-5.66) and likelihood ratio (3.6; detection rate: false
positive rate) of any feature examined, and was strongly associated with
mortality, regardless of disease stage. Functional assays showed that OSCC
cells can modulate myoﬁbroblast transdifferentiation through avb6-
dependent TGF-b1 activation and that myoﬁbroblasts promote OSCC
invasion. Finally, we developed a prognostic model using Cox regression
with backward elimination; only SMA expression, metastasis, cohesion,
and age were signiﬁcant. This model was independently validated on
a patient subset (detection rate 70%; false positive rate 20%; ROC analysis
77%, p < 0.001).
Conclusion: Our study highlights the importance of the tumour stroma in
OSCC, identiﬁes a powerful prognostic indicator and potential new target
for molecular therapies.* SARS Academic and Research Prize 0904 CIRCULATING MICRORNA
SIGNATURES: A NOVEL BIOMARKER IN PROSTATE CANCER
Brian Kelly 1, Nicola Miller 1, Garrett Durkan 2, Eamonn Rogers 2, Kilian
Walsh 2, Michael Kerin 1. 1National University of Ireland, Galway, Galway,
Ireland; 1Galway University Hospital, Galway, Ireland
Aim: Mi(cro)RNAs are small non-coding RNAs whose differential expres-
sion in tissue has been implicated in the development and progression of
prostate cancer. The detection of these miRNAs in the circulation has
stimulated their investigation as novel biomarkers in prostate cancer. The
aim of this study was to investigate the expression of a panel of candidate
miRNAs in the circulation of prostate cancer patients.
Methods: RNAwas extracted fromwhole-blood samples from 65 patients,
37 with prostate cancer and 28 benign samples. Samples were reverse-
transcribed using stem-loop primers and expression levels of 10 candidate
miRNAs were determined using real-time quantitative-PCR. MiRNA
expression levels were then correlated with clinicopathological data.
Results: The analysis of miRNA mean expression levels revealed that
circulating levels of the tumour suppressor let-7a (p¼0.01) along with the
oncogenic miR-141 (p¼0.005) could clearly differentiate prostate cancer
patients from patients with benign disease. Using these miRNAs in
combination increases the speciﬁcity and the sensitivity, to levels similar
to that of PSA.
Conclusion: Our ﬁndings clearly identify signiﬁcant differences in
expression levels of oncogenic and tumour suppressor miRNAs in the
bloodstream of prostate cancer patients. This highlights their potential use
as novel biomarkers of prostate cancer as an adjunct to PSA.ASiT Short Paper Prize 0663 THE VALUE OF HYPERBILIRUBINAEMIA IN
THE DIAGNOSIS OF ACUTE APPENDICITIS
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Aim: No reliably speciﬁc marker for acute appendicitis has been identiﬁed.
Studies have shown hyperbilirubinaemia to be a predictor of appendiceal
perforation, but did not focus on bilirubin as a speciﬁc marker for acute
appendicitis. The aim of this study was to determine the value of hyper-
bilirubinaemia as a marker for acute appendicitis.
Methods: A retrospective analysis of appendicectomies (n¼472). Patients
were grouped according to histology ﬁndings and comparisons made
between groups.
Results: Mean bilirubin levels were higher for patients with simple
appendicitis compared to those with a non-inﬂamed appendix (p<0.001).
More patients with simple appendicitis had hyperbilirubinaemia on
admission (30% vs. 12%) and the odds of these patients having appendicitis
were over 3 times higher (OR 3.25, p<0.001). Hyperbilirubinaemia had
a speciﬁcity of 88% and a positive predictive value of 91% for acute
appendicitis. Patients with appendicitis with a perforated or gangrenous
appendix had higher mean bilirubin levels (p¼0.01) and were more likely
